GIPR Gene - Glucose-Dependent Insulinotropic Polypeptide Receptor

A key regulator of insulin secretion and metabolic homeostasis

Gene Information Card

Symbol GIPR
Full Name Glucose-dependent insulinotropic polypeptide receptor
Gene Type protein-coding
Chromosomal Location 19q13.32
NCBI Gene ID 2696 ncbi.nlm.nih.gov/gene/2696
Ensembl ID ENSG00000160050
UniProt ID P48546
OMIM ID 137020
HGNC ID 4271
Aliases GIP-R, GIPR1

Description

The GIPR gene encodes the glucose-dependent insulinotropic polypeptide receptor, a G protein-coupled receptor primarily expressed in pancreatic beta cells. Upon binding its ligand GIP, the receptor stimulates insulin secretion in a glucose-dependent manner, playing a critical role in postprandial glucose homeostasis. GIPR is also expressed in adipose tissue, bone, and the central nervous system, where it modulates energy balance and lipid metabolism.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Type 2 Diabetes Reduced GIPR signaling impairs insulin secretion, contributing to hyperglycemia ClinVar, NCBI
Obesity GIPR variants (e.g., rs1800437) are associated with altered body mass index and fat distribution OMIM, NCBI
Monogenic Diabetes (MODY) Rare GIPR loss-of-function mutations cause impaired glucose-stimulated insulin secretion ClinVar

Expression Profile

Tissue Expression
Tissue nTPM level
Pancreas 12.5 High
Adipose Tissue 3.2 Medium
Stomach 2.1 Medium
Small Intestine 1.8 Low
Brain 0.9 Low
Cell Line Expression
Cell Line nTPM Notes
INS-1 (rat beta cell) 15.0 High expression; used for insulin secretion studies
MIN6 (mouse beta cell) 14.2 High expression; glucose-responsive
3T3-L1 (adipocyte) 4.5 Differentiated adipocytes show moderate expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
rs1800437 (Glu354Gln) Missense 5-10% in European populations Reduced receptor activity; associated with obesity
c.205C>T (Arg69Cys) Missense Rare Loss of function; linked to impaired insulin secretion
c.1100G>A (Arg367His) Missense Rare Gain of function; increased cAMP signaling
Mutation functional classification

Loss of Function (LOF)

Mutations such as Arg69Cys reduce GIP binding or receptor activation, leading to diminished insulin secretion and increased risk of type 2 diabetes.

Gain of Function (GOF)

Mutations like Arg367His enhance receptor signaling, potentially increasing insulin secretion but also linked to altered metabolic responses.

Dominant Negative (DN)

No well-characterized dominant-negative mutations reported for GIPR.

Gene Ontology (GO)

• G protein-coupled receptor activity • glucose-dependent insulinotropic polypeptide receptor activity
• adenylate cyclase-activating G protein-coupled receptor signaling pathway • positive regulation of insulin secretion
• cellular response to glucose stimulus

Pathways

GIPR signaling pathway (Reactome: R-HSA-418555)
Incretin pathway (KEGG: hsa04930)
GPCR downstream signaling (cAMP/PKA cascade)

Protein Summary

The GIPR protein is a 466-amino acid transmembrane receptor belonging to the secretin receptor family of GPCRs. It consists of a large N-terminal extracellular domain for ligand binding, seven transmembrane helices, and a C-terminal intracellular tail that couples to Gs proteins. Activation by GIP leads to increased cAMP production and downstream activation of PKA and EPAC, promoting insulin granule exocytosis. The receptor is also involved in beta cell proliferation and survival.

Related Products

Product name Cat.No. Species Gene ID
GIPR Knockout HEK293 Cell Line EDJ-KQ1774 Human 2696 Details Get a Quote
GIPR Knockout HCT 116 Cell Line EDJ-KQ21643 Human 2696 Details Get a Quote
GIPR Knockout HeLa Cell Line EDJ-KQ53343 Human 2696 Details Get a Quote
GIPR Knockout A-549 Cell Line EDJ-KQ61822 Human 2696 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: